Renaissance Group Has Lowered By $2.20 Million Its Synopsys (SNPS) Position; Cormorant Asset Management Has Lowered By $1.49 Million Its Neurocrine Biosciences (NBIX) Holding

May 25, 2017 - By Nellie Frank

Cormorant Asset Management Llc decreased Neurocrine Biosciences Inc (NBIX) stake by 9.87% reported in 2016Q4 SEC filing. Cormorant Asset Management Llc sold 39,301 shares as Neurocrine Biosciences Inc (NBIX)’s stock rose 19.84%. The Cormorant Asset Management Llc holds 359,000 shares with $13.89M value, down from 398,301 last quarter. Neurocrine Biosciences Inc now has $3.93 billion valuation. It closed at $48.89 lastly. It is down 12.51% since May 25, 2016 and is uptrending. It has underperformed by 4.19% the S&P500.

Renaissance Group Llc decreased Synopsys Inc (SNPS) stake by 6.55% reported in 2016Q4 SEC filing. Renaissance Group Llc sold 38,004 shares as Synopsys Inc (SNPS)’s stock rose 0.68%. The Renaissance Group Llc holds 542,556 shares with $31.94 million value, down from 580,560 last quarter. Synopsys Inc now has $11.04 billion valuation. It closed at $73.03 lastly. It is down 45.65% since May 25, 2016 and is uptrending. It has outperformed by 28.95% the S&P500.

Since January 10, 2017, it had 0 insider buys, and 35 insider sales for $11.83 million activity. Shares for $41,544 were sold by Bozigian Haig P. on Monday, February 6. Another trade for 10,000 shares valued at $532,700 was made by Lippoldt Darin on Thursday, May 18. GORMAN KEVIN CHARLES had sold 3,750 shares worth $152,438 on Tuesday, January 17. Shares for $550,000 were sold by Grigoriadis Dimitri E.. BENEVICH ERIC sold $41,287 worth of stock. On Friday, February 3 Coughlin Timothy P sold $63,825 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) or 1,500 shares. On Tuesday, January 17 the insider OBrien Christopher Flint sold $71,155.

Investors sentiment decreased to 1.06 in 2016 Q4. Its down 0.03, from 1.09 in 2016Q3. It dived, as 33 investors sold NBIX shares while 67 reduced holdings. 23 funds opened positions while 83 raised stakes. 82.52 million shares or 1.88% less from 84.11 million shares in 2016Q3 were reported. The Brazil-based Jgp Glob Gestao De Recursos Ltda has invested 0.11% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Jefferies Grp Llc accumulated 9,216 shares. 531,100 were accumulated by Timessquare Management Limited Liability Corp. Cubist Systematic Strategies Lc owns 8,779 shares. Arrowpoint Asset Mgmt Limited invested in 0.55% or 891,527 shares. Fmr Limited Liability owns 12.95 million shares or 0.07% of their US portfolio. Putnam Invs Llc, a Massachusetts-based fund reported 27,348 shares. Alliancebernstein Lp holds 1.02M shares or 0.03% of its portfolio. Dekabank Deutsche Girozentrale has invested 0.03% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Pub Employees Retirement Association Of Colorado holds 143,328 shares or 0.04% of its portfolio. Rhumbline Advisers holds 0.01% or 107,220 shares in its portfolio. Eventide Asset Mgmt has 125,000 shares. Pictet Asset Mngmt invested 0.11% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). 2.36 million were accumulated by Janus Cap Mgmt Lc. Two Sigma Secs Ltd Liability invested in 5,185 shares.

Among 9 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 10 analyst reports since August 18, 2015 according to SRatingsIntel. The firm has “Buy” rating by Deutsche Bank given on Thursday, November 3. H.C. Wainwright initiated the shares of NBIX in report on Wednesday, June 29 with “Buy” rating. The firm has “Outperform” rating given on Friday, January 27 by Oppenheimer. As per Thursday, April 7, the company rating was initiated by BMO Capital Markets. Piper Jaffray maintained Neurocrine Biosciences, Inc. (NASDAQ:NBIX) rating on Thursday, October 8. Piper Jaffray has “Overweight” rating and $96 target. The stock has “Perform” rating by Oppenheimer on Tuesday, November 22. Leerink Swann maintained Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Monday, October 12 with “Outperform” rating. Needham initiated it with “Buy” rating and $62 target in Tuesday, October 18 report. The stock of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has “Buy” rating given on Tuesday, August 18 by Jefferies.

Cormorant Asset Management Llc increased Ascendis Pharma A S stake by 100,000 shares to 162,254 valued at $3.28M in 2016Q4. It also upped Proteostasis Therapeutics In stake by 1.45 million shares and now owns 3.80 million shares. Fulgent Genetics Inc was raised too.

Renaissance Group Llc increased Advanced Semiconductor Engine (NYSE:ASX) stake by 107,281 shares to 2.45 million valued at $12.33 million in 2016Q4. It also upped Nippon Telephone & Telegraph A (NYSE:NTT) stake by 7,660 shares and now owns 295,646 shares. China Mobile Ltd (NYSE:CHL) was raised too.

Among 7 analysts covering Synopsys Inc. (NASDAQ:SNPS), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Synopsys Inc. had 16 analyst reports since August 20, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, August 18 by DA Davidson. The stock of Synopsys, Inc. (NASDAQ:SNPS) has “Hold” rating given on Wednesday, September 9 by Benchmark. As per Friday, August 28, the company rating was initiated by Bank of America. Credit Suisse initiated the shares of SNPS in report on Wednesday, October 19 with “Outperform” rating. The stock of Synopsys, Inc. (NASDAQ:SNPS) earned “Buy” rating by Needham on Thursday, August 18. As per Monday, June 6, the company rating was initiated by RBC Capital Markets. maintained the shares of SNPS in report on Monday, October 10 with “Buy” rating. The stock of Synopsys, Inc. (NASDAQ:SNPS) earned “Buy” rating by Needham on Thursday, December 1. The firm has “Buy” rating by Pacific Crest given on Tuesday, August 25. On Thursday, August 18 the stock rating was maintained by Benchmark with “Hold”.

Investors sentiment decreased to 0.84 in Q4 2016. Its down 0.55, from 1.39 in 2016Q3. It worsened, as 30 investors sold SNPS shares while 149 reduced holdings. 35 funds opened positions while 116 raised stakes. 129.15 million shares or 2.90% less from 133.01 million shares in 2016Q3 were reported. 204 were reported by Washington Trust Bank & Trust. Oakbrook Ltd Liability Co holds 13,000 shares. Verition Fund Mgmt Limited Liability Corp invested in 0.09% or 16,915 shares. Nuveen Asset Limited Liability, a Illinois-based fund reported 120,250 shares. Voya Inv Mgmt Lc invested in 66,056 shares. Ny State Teachers Retirement Sys invested 0.04% of its portfolio in Synopsys, Inc. (NASDAQ:SNPS). Tower Capital Limited Liability Company (Trc) holds 0% of its portfolio in Synopsys, Inc. (NASDAQ:SNPS) for 323 shares. Jacobs Levy Equity Incorporated invested 0.47% in Synopsys, Inc. (NASDAQ:SNPS). Hancock Hldgs Com has 278,304 shares for 0.61% of their portfolio. Marshall Wace Llp accumulated 193,697 shares. Keybank Association Oh invested in 0% or 8,298 shares. Victory Capital Management Inc has 0.24% invested in Synopsys, Inc. (NASDAQ:SNPS). Graybill Bartz And Associate holds 2.13% of its portfolio in Synopsys, Inc. (NASDAQ:SNPS) for 42,400 shares. Texas Permanent School Fund has 0.09% invested in Synopsys, Inc. (NASDAQ:SNPS). Oak Ltd Oh owns 131,000 shares for 0.76% of their portfolio.

Since December 2, 2016, it had 0 insider purchases, and 15 selling transactions for $31.89 million activity. Shares for $3.08 million were sold by CHAN CHI-FOON. 12,000 shares valued at $847,398 were sold by CASTINO ALFRED on Tuesday, February 21. $567,023 worth of Synopsys, Inc. (NASDAQ:SNPS) was sold by RUNKEL JOHN F JR on Friday, December 2. $280,450 worth of Synopsys, Inc. (NASDAQ:SNPS) was sold by Logan Joseph W. Shares for $18.75M were sold by DE GEUS AART on Friday, May 19. Another trade for 9,074 shares valued at $644,396 was sold by WALSKE STEVEN. Pham Trac sold 39,899 shares worth $2.84M.